To compare complications after PVE in patients with ductal CCC versus CRC liver metastases and identify possible predictive factors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028692

Enrollment

200

Registered

2022-04-05

Start date

2020-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal carcinoma, cholangiocellular carcinoma

Interventions

Group 1: Liver metastases of colorectal carcinoma Group 2: cholangiocellular carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: PVE for liver metastases of colorectal carcinoma or ductal cholangiocellular carcinoma

Exclusion criteria

Exclusion criteria: no follow-up no match for gender and age

Design outcomes

Primary

Measure	Time frame
complication rate and grade of the two tumor entities	—

Secondary

Measure	Time frame
predictie factors for complications	—

Countries

Germany

Contacts

Public ContactFrederic De Beukelaer

Klinik für diagnostische und interventionelle Radiologie

fdebeukelaer@ukaachen.de004924180100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026